Adicet Bio Inc. (United States) is listed on the Nasdaq and has a market capitalization of $82.20 Millions, with shareholders equity totaling $159.21 Millions.
The company employs approximately 102 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Adicet Bio Inc. reported $- in revenue, generating net income of $-116.81 Millions.
Key financial metrics include a P/E ratio of -0.70, a price-to-book (P/B) ratio of 0.52, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ACET.